Popular search terms:
Search Results
56 results found-
Current Clinical Trials
CSL Behring conducts clinical trials to ensure our products are safe and effective for our patients. Learn more.
https://www.cslbehring.com/...ehring/current-clinical-trials -
Your Rights and Responsibilities | CSL Behring
CSL Behring's clinical trial subjects are entitled to specific rights. A clinical trial investigation must comply with a specific plan or protocol. Learn more.
https://www.cslbehring.com/...ur-rights-and-responsibilities -
What is a Clinical Trial
CSL Behring conducts clinical trials to ensure our products are safe and effective for our patients. Learn more.
https://www.cslbehring.com/...hring/what-is-a-clinical-trial -
Questions to Ask | CSL Behring
CSL Behring can provide you with a number of questions to ask the study investigator or coordinator before enrolling in a study. Learn more.
https://www.cslbehring.com/...ial/frequently-asked-questions -
CSL Behring | Global Life Saving Biotherapies, Plasma Protein
CSL Behring is a global biotechnology leader driven by its promise to save and improve lives.
https://www.cslbehring.com -
Research Practices| CSL Behring
CSL Behring conducts clinical trials to ensure our products are safe and effective for our patients. Learn more.
https://www.cslbehring.com/...csl-behring/research-practices -
Clinical Studies at CSL Behring | CSL Behring
CSL Behring conducts clinical trials to ensure our products are safe and effective for our patients. Learn more.
https://www.cslbehring.com/...linical-studies-at-csl-behring -
R&D Capabilities | CSL Behring
CSL Behring is driven to improve and save lives. We work tirelessly to innovate in the areas of plasma therapies, recombinant proteins & more.
https://www.cslbehring.com/r-and-d/r-and-d-capabilities -
Fibrinogen Deficiency
CSL Behring has developed several plasma-derived therapies for treating hereditary bleeding disorders. Learn more.
https://www.cslbehring.com/...isorders/fibrinogen-deficiency -
Therapeutic Goods Administration Approves AFSTYLA® - CSL Behring
AFSTYLA is the first and only single-chain recombinant factor VIII product to treat haemophilia A.
http://www.cslbehring.com/...m/20170419-afstyla-aus-approval